4c aims to generate a sustainable infrastructure that optimizes the delivery of clinical trials in children through:
a) a single point of contact for all sponsors, sites and investigators;
b) efficient implementation of trials, adopting consistent approaches, aligned quality standards and coordination of sites at national and international level;
c) collaboration with specialist and national networks;
d) high quality input into study design and preparation, through rigorous strategic and operational feasibility assessment;
e) the promotion of innovative trial design and quantitative scientific methods;
f) an education and training platform to shape the future leaders of paediatric drug development;
g) the development of sustainable support for all these activities.